Table 1

Mean per cent improvement in quality of life at six months^1-150 (Phase III)

Variable		Placebo (n=80)		Etanercept
Variable		Placebo (n=80)		10 mg (n=76)	25 mg (n=78)
Disability Index	2	34^1-151	39^1-151
General health status	−12	34^1-151	33^1-151
Arthritis specific health status	−22	31^1-151	44^1-151
Vitality	2	22^1-151	25^1-151
Mental health	3	17	35^1-151 ^1-152

↵1-150 Positive numbers represent improvement, negative numbers represent worsening.
↵1-151 p <0.05 for etanercept groups compared with placebo group.
↵1-152 p <0.05 for etanercept 10 mg compared with etanercept 25 mg.